S24 Fueling Hormone-Dependent Cancers: Lifestyle to Lipids

Program: Symposia
Bench to Bedside Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 156 (BCEC)
Colleen C. Nelson, PhD, Queensland University of Technology, Brisbane, Queensland, Australia

Nothing to Disclose: CCN
8:15 AM
Dipali Sharma, PhD, Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medical Institutions, Baltimore, MD
Nothing to Disclose: DS
8:45 AM
Lorelei Mucci, MPH, ScD, Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
Nothing to Disclose: LM
9:15 AM
Matthew James Watt, PhD, Physiology, Monash University, Clayton Vic, Australia
Nothing to Disclose: MJW
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire